Global Eosinophilic Esophagitis Market Size, Share, and COVID-19 Impact Analysis By Drug Class ({ Corticosteroids (Budesonide (Jorveza, Off-label budesonide), Fluticasone), Proton Pump Inhibitor (PPI) (Omeprazole, Esomeprazole, Others), and Late Stage Pipeline Drugs (Dupixent, APT-1011, Lirentelimab (AK002), Cendakimab, Etrasimod, TAK-721, Omilancor (BT-11) }), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.

Industry: Healthcare
RELEASE DATE Oct 2022
REPORT ID SI1258
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Drug Class
      2. Market Attractiveness Analysis By Distribution Channel
      3. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1.   Increasing awareness about the disease
    3. Restraints
      1.  Impending drug approvals
    4. Opportunities
      1.  Increased clinical research and activities
    5. Challenge

5.5.1.    High cost

  1. Global Eosinophilic Esophagitis Market Analysis and Projection, By Drug Class
    1. Segment Overview
    2.  Corticosteroids
    3. Proton Pump Inhibitor
    4. LateStage Pipeline Drugs
  2. Global Eosinophilic Esophagitis Market Analysis and Projection, By Distribution Channel
    1.  Segment Overview
    2.   Hospital Pharmacies
    3. Retail Pharmacies
    4. Online Pharmacies
  3. Global Eosinophilic Esophagitis Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  4. Global Eosinophilic Esophagitis Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Eosinophilic Esophagitis Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  5. Company Profiles
    1.   Takeda Pharmaceutical Company Limited (Japan)
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
    2. SWOT Analysis
  6.  Ellodi Pharmaceuticals (U.S.)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  7.   Bristol-Myers Squibb Company (U.S.)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  8.   AstraZeneca (U.K.)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  9.   GSK plc (U.S.)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  10.   Regeneron Pharmaceuticals Inc. (U.S.)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  11.   Allakos Inc (U.S.)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  12. Arena Pharmaceuticals Ltd (U.S.)  
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  13.  Revolo Biotherapeutics (U.S.)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  14.      DBV Technologies (France)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  15.   Cipla Inc (India)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  16.  Pharmaceutical Industries Ltd (India)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  17.   Sanofi (France)
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis

List of Table

  1. Global Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  2. Global Corticosteroids, Eosinophilic Esophagitis Market, By Region, 2022-2030(USD million)
  3. Global Proton Pump Inhibitor, Eosinophilic Esophagitis Market, By Region, 2022-2030(USD million)
  4. Globa LateStage Pipeline Drugs, Eosinophilic Esophagitis Market, By Region, 2022-2030(USD million)
  5. Global Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  6. Global Hospital Pharmacies, Eosinophilic Esophagitis Market, By Region, 2022-2030(USD million)
  7. Global Retail Pharmacies, Eosinophilic Esophagitis Market, By Region, 2022-2030(USD million)
  8. Global Online Pharmacies, Eosinophilic Esophagitis Market, By Region, 2022-2030(USD million)
  9. Global Eosinophilic Esophagitis Market, By Region, 2022-2030(USD million)
  10. North America Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  11. North America Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  12. U.S.  Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  13. U.S.  Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  14. Canada Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  15. Canada Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  16. Mexico Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  17. Mexico Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  18. Europe Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  19. Europe Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  20. Germany Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  21. Germany Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  22. France Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  23. France Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  24. U.K.  Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  25. U.K.  Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  26. Italy Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  27. Italy Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  28. Spain Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  29. Spain Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  30. Asia Pacific Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  31. Asia Pacific Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  32. Japan Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  33. Japan Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  34. China Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  35. China Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  36. India Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  37. India Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  38. South America Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  39. South America Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  40. Brazil Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  41. Brazil Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  42. The Middle East and Africa Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD   million)
  43. The Middle East and Africa Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)
  44. UAE Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  45. UAE Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million) 
  46. South Africa Eosinophilic Esophagitis Market, By Drug Class, 2022-2030(USD million)
  47. South Africa Eosinophilic Esophagitis Market, By Distribution Channel, 2022-2030(USD million)

List of Figures 

  1. Global Eosinophilic Esophagitis Market Segmentation
  2.  Eosinophilic Esophagitis Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Eosinophilic Esophagitis Market
  9. Top Winning Strategies, 2022-2030
  10. Top Winning Strategies, By Development, 2022-2030(%)
  11. Top Winning Strategies, By Company, 2022-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Eosinophilic Esophagitis Market
  20.  Eosinophilic Esophagitis Market Segmentation, By Drug Class
  21. Eosinophilic Esophagitis Market For Corticosteroids, By Region, 2022-2030 ($ million
  22.  Eosinophilic Esophagitis Market For Proton Pump Inhibitor, By Region, 2022-2030 ($ million)
  23.  Eosinophilic Esophagitis Market For LateStage Pipeline Drugs, By Region, 2022-2030 ($ million)
  24.  Eosinophilic Esophagitis Market Segmentation, By Distribution Channel
  25.  Eosinophilic Esophagitis Market For Hospital Pharmacies, By Region, 2022-2030 ($ million)
  26.  Eosinophilic Esophagitis Market For Retail Pharmacies, By Region, 2022-2030 ($ million)
  27. Eosinophilic Esophagitis Market For Online Pharmacies, By Region, 2022-2030 ($ million)
  28. Procter & Gamble: Net Sales, 2022-2030 ($ million)
  29. Procter & Gamble: Revenue Share, By Segment, 2022 (%)
  30. Procter & Gamble: Revenue Share, By Region, 2022 (%)
  31. PHYTOMER: Net Sales, 2022-2030 ($ million)
  32. PHYTOMER: Revenue Share, By Segment, 2022 (%)
  33. PHYTOMER: Revenue Share, By Region, 2022 (%)
  34. Deka Corporation: Net Sales, 2022-2030 ($ million)
  35. Deka Corporation: Revenue Share, By Segment, 2022 (%)
  36. Deka Corporation: Revenue Share, By Region, 2022 (%)
  37. Johnson & Johnson: Net Sales, 2022-2030 ($ million)
  38. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  39. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  40. Unilever Plc.: Net Sales, 2022-2030 ($ million)
  41. Unilever Plc.: Revenue Share, By Segment, 2022 (%)
  42. Unilever Plc.: Revenue Share, By Region, 2022 (%)
  43. Kao Corporation: Net Sales, 2022-2030 ($ million)
  44. Kao Corporation: Revenue Share, By Segment, 2022 (%)
  45. Kao Corporation: Revenue Share, By Region, 2022 (%)
  46. ZO Skin Health, Inc.: Net Sales, 2022-2030 ($ million)
  47. ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
  48. ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
  49. L’Oreal Paris: Net Sales, 2022-2030 ($ million)
  50. L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
  51. L’Oreal Paris: Revenue Share, By Region, 2022 (%)
  52. Shiseido Company Limited: Net Sales, 2022-2030 ($ million)
  53. Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
  54. Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
  55. Estee Lauder Companies, Inc.: Net Sales, 2022-2030 ($ million)
  56. Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
  57. Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:104
Pages:200
Countries covered:17
Companies covered::13
Forecast CAGR:34%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies